Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 7, 2025Journal of Hospital MedicineOpen Access

Diagnosis and management of reactive infectious mucocutaneous eruption

View Full Paper
Ask AI
Bookmark
Share

Authors

NDNicole DamariCincinnati Children's Hospital Medical CenterAGAnthony A. GoodmanBreast CenterCBCatherine BridgesNatera (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Damari et al. (2025) studied this question.

synapsesocial.com/papers/69d6c603a0177bf533ed8f3dhttps://doi.org/10.1002/jhm.70099
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Reactive infectious mucocutaneous eruption following COVID ‐19 in an adolescent boy: Case report and review of the literature2022 · 14 citations
  2. 2SARS‐CoV‐2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment2024 · 5 citations
  3. 3Evaluation of Etanercept for Treatment of Reactive Infectious Mucocutaneous Eruption2021 · 27 citations
  4. 4Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions2018 · 291 citations
  5. 5Adenoviral‐induced rash and mucositis: Expanding the spectrum of reactive infectious mucocutaneous eruption2020 · 33 citations